-
Signature
-
/s/ Amy Trombly as attorney-in-fact
-
Issuer symbol
-
SNOA
-
Transactions as of
-
02 Jan 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
02 Jan 2026, 17:20:29 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Birnbaum Jay E |
Director |
C/O SONOMA PHARMACEUTICALS, INC., 5445 CONESTOGA COURT, SUITE 150, BOULDER |
/s/ Amy Trombly as attorney-in-fact |
02 Jan 2026 |
0001397470 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SNOA |
Stock option (right to buy) |
Award |
|
+10,000 |
+100% |
|
20,001 |
02 Jan 2026 |
Common Stock |
10,000 |
$3.68 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Jay E. Birnbaum is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses: